STOCK TITAN

Bruker Announces Quarterly Dividend

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
dividends

Bruker (BRKR) has announced that its Board of Directors has approved a quarterly cash dividend of $0.05 per share on the Company's common stock. The dividend will be paid on March 28, 2025 to stockholders of record as of March 17, 2025.

Bruker (BRKR) ha annunciato che il suo Consiglio di Amministrazione ha approvato un dividendo in contante trimestrale di $0,05 per azione sulle azioni ordinarie della Società. Il dividendo sarà pagato il 28 marzo 2025 agli azionisti registrati al 17 marzo 2025.

Bruker (BRKR) ha anunciado que su Junta Directiva ha aprobado un dividendo en efectivo trimestral de $0.05 por acción sobre las acciones ordinarias de la Compañía. El dividendo se pagará el 28 de marzo de 2025 a los accionistas registrados al 17 de marzo de 2025.

Bruker (BRKR)는 이사회가 회사의 보통주에 대해 주당 $0.05의 분기 현금 배당금을 승인했다고 발표했습니다. 배당금은 2025년 3월 28일2025년 3월 17일 기준 주주에게 지급될 예정입니다.

Bruker (BRKR) a annoncé que son Conseil d'Administration a approuvé un dividende en espèces trimestriel de 0,05 $ par action sur les actions ordinaires de la Société. Le dividende sera versé le 28 mars 2025 aux actionnaires enregistrés au 17 mars 2025.

Bruker (BRKR) hat bekannt gegeben, dass der Vorstand eine vierteljährliche Bar-Dividende von 0,05 $ pro Aktie auf die Stammaktien des Unternehmens genehmigt hat. Die Dividende wird am 28. März 2025 an die zum 17. März 2025 eingetragenen Aktionäre ausgezahlt.

Positive
  • Consistent dividend payment demonstrates financial stability
  • Regular cash return to shareholders
Negative
  • None.

BILLERICA, Mass.--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock. The dividend will be paid on March 28, 2025 to stockholders of record as of March 17, 2025.

About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)

Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.

Forward-Looking Statements

Any statements contained in this press release which do not describe historical facts may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding expected quarterly cash dividends in 2025. Any forward-looking statements contained herein are based on current expectations, but are subject to risks and uncertainties that could cause actual results to differ materially from those indicated, including, but not limited to, those risk factors discussed from time to time in our filings with the Securities and Exchange Commission, or SEC. These and other factors are identified and described in more detail in our filings with the SEC, including, without limitation, our annual report on Form 10-K for the year ended December 31, 2023, as may be updated by our quarterly reports on Form 10-Q. We expressly disclaim any intent or obligation to update these forward-looking statements other than as required by law.

Joe Kostka

Director, Investor Relations

Bruker Corporation

T: +1 (978) 313-5800

E: Investor.Relations@bruker.com

Source: Bruker Corporation

FAQ

What is the amount of Bruker's (BRKR) quarterly dividend for March 2025?

Bruker's quarterly dividend amount is $0.05 per share for March 2025.

When is the payment date for Bruker's (BRKR) March 2025 dividend?

The dividend payment date is March 28, 2025.

What is the record date for Bruker's (BRKR) March 2025 dividend?

The record date is March 17, 2025.

How often does Bruker (BRKR) pay dividends?

Bruker pays dividends on a quarterly basis.

Bruker Corp

NASDAQ:BRKR

BRKR Rankings

BRKR Latest News

BRKR Stock Data

8.02B
103.14M
31.92%
80.34%
4.12%
Medical Devices
Laboratory Analytical Instruments
Link
United States
BILLERICA